Back to Stakeholders
Categories

2 domains / 4 areas / 2 specializations

Care Delivery & Psychedelic Facilitation
Care Delivery & Psychedelic Facilitation
Clinical Care Delivery OrganizationsHealth Systems & Hospitals
Research, Drug Development & Manufacturing
Academic & Non-Profit ResearchUniversities and Colleges without Dedicated Psychedelic Research Groups
Research, Drug Development & Manufacturing

Peking University First Hospital

China
6 Trials

Leading academic hospital in Beijing affiliated with Peking University. Has conducted ketamine clinical trials including a randomized study of low-dose ketamine for perinatal depression, contributing to China's growing body of research on rapid-acting antidepressant therapies.

Academic Research

0 papers

Published Papers

0

Trial Involvement

6

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
Other
HQ
China
Website
Visit

Sponsored Trials

6
Not yet recruitingNA

Intranasal Dexmedetomidine-Esketamine for Sleep and Cognition in Older Adults With Mild-to-Moderate Cognitive Impairment

Start Date
Compounds
Esketamine, Placebo
Unknown statusNA

Esketamine Adjuvant Therapy for Patients With Chronic Visceral Pain Comorbid Major Depressive Disorder

Start Date
Compounds
Placebo, Esketamine
Active not recruitingIV

Effect of Low-dose Esketamine on Maternal Depression at 2 Years After Childbirth

Start Date
Compounds
Esketamine, Placebo
CompletedNA

Low-dose S-Ketamine and Postpartum Depression in Parturients With Prenatal Depression

Start Date
Compounds
Esketamine, Placebo
CompletedNA

Low-dose S-ketamine in Women With Prenatal Depression

Start Date
Compounds
Ketamine, Placebo
CompletedIV

Low-dose Ketamine and Postpartum Depression in Parturients With Prenatal Depression

Start Date
Compounds
Ketamine, Placebo